Showing 1 - 8 results of 8 for search 'Mashiro Okunaka', query time: 0.03s Refine Results
  1. 1
    Nuclear Receptor and Stress Response Pathways Associated with Antineoplastic Agent-Induced Diarrhea

    Nuclear Receptor and Stress Response Pathways Associated with Antineoplastic Agent-Induced Diarrhea by Mashiro Okunaka, Daisuke Kano, Yoshihiro Uesawa

    Published 2022-10-01
    Get full text
    Article
  2. 2
    Evaluation of the Expression Profile of Irinotecan-Induced Diarrhea in Patients with Colorectal Cancer

    Evaluation of the Expression Profile of Irinotecan-Induced Diarrhea in Patients with Colorectal Cancer by Mashiro Okunaka, Daisuke Kano, Reiko Matsui, Toshikatsu Kawasaki, Yoshihiro Uesawa

    Published 2021-04-01
    Get full text
    Article
  3. 3
    Comprehensive Analysis of Chemotherapeutic Agents That Induce Infectious Neutropenia

    Comprehensive Analysis of Chemotherapeutic Agents That Induce Infectious Neutropenia by Mashiro Okunaka, Daisuke Kano, Reiko Matsui, Toshikatsu Kawasaki, Yoshihiro Uesawa

    Published 2021-07-01
    Get full text
    Article
  4. 4
    Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer

    Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric c... by Mashiro Okunaka, Daisuke Kotani, Ken Demachi, Akihito Kawazoe, Takayuki Yoshino, Toshikatsu Kawasaki, Kohei Shitara

    Published 2020-11-01
    Get full text
    Article
  5. 5
    Prognosis of patients with residual pathological disease after neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy and surgery for esophageal squamous cell carcinoma: a retrospective cohort study

    Prognosis of patients with residual pathological disease after neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy and surgery for esophageal squamous cell carcinoma: a re... by Mashiro Okunaka, Daisuke Kotani, Hisashi Fujiwara, Kazuma Sato, Naoto Fujiwara, Saori Mishima, Shingo Sakashita, Takayuki Yoshino, Takeo Fujita, Takashi Kojima

    Published 2024-02-01
    Get full text
    Article
  6. 6
    The efficacy and safety of paclitaxel plus bevacizumab therapy in breast cancer patients with visceral crisis

    The efficacy and safety of paclitaxel plus bevacizumab therapy in breast cancer patients with visceral crisis by Chikako Funasaka, Yoichi Naito, Shota Kusuhara, Takehiro Nakao, Yoko Fukasawa, Kanako Mamishin, Ayumi Komuro, Mashiro Okunaka, Chihiro Kondoh, Kenichi Harano, Takahiro Kogawa, Nobuaki Matsubara, Ako Hosono, Toshikatsu Kawasaki, Toru Mukohara

    Published 2021-08-01
    Get full text
    Article
  7. 7
    Improved efficacy of taxanes and ramucirumab combination chemotherapy after exposure to anti-PD-1 therapy in advanced gastric cancer

    Improved efficacy of taxanes and ramucirumab combination chemotherapy after exposure to anti-PD-1 therapy in advanced gastric cancer by Saori Mishima, Akihito Kawazoe, Yasutoshi Kuboki, Takashi Kojima, Toshihiko Doi, Takayuki Yoshino, Kohei Shitara, Yoshiaki Nakamura, Kentaro Sawada, Hiroya Taniguchi, Daisuke Kotani, Akinori Sasaki, Testuya Eto, Mashiro Okunaka, Tetsuo Akimoto

    Published 2020-10-01
    Get full text
    Article
  8. 8
    Potential Efficacy of Shiunko for Anti-Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody-Induced Skin Fissure: A Single Institutional Case Series

    Potential Efficacy of Shiunko for Anti-Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody-Induced Skin Fissure: A Single Institutional Case Series by Mashiro Okunaka PhD, Daisuke Kotani MD, PhD, Saori Mishima MD, PhD, Maho Nakamura, Akihito Kawazoe MD, PhD, Hideaki Bando MD, PhD, Takayuki Yoshino MD, PhD, Kohei Shitara MD

    Published 2024-01-01
    Get full text
    Article

Search Tools: